Investigación y manejo | 11 AGO 14

Infección por el VIH de reciente diagnóstico

La mayoría de los pacientes con diagnóstico reciente de infección por el VIH pueden tener una expectativa de vida normal, saludable y productiva si el diagnóstico es oportuno.
Autor/a: Dres. Michael Rayment, David Asboe, Ann K Sullivan. BMJ 2014;349:g42755
INDICE:  1.  | 2. Referencias
Referencias

1 British HIV Association. British Association for Sexual Health and HIV (BASHH), the British HIV Association (BHIVA), and the British Infection Society (BIS) guidelines for HIV testing. 2008. www.bhiva.org/HIVTesting2008.aspx.
2 May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy: UK cohort study. AIDS 2014; published online 19 Feb.
3 Health Protection Agency. HIV in the United Kingdom: 2013 report. www.hpa.org.uk/Publications/InfectiousDiseases/HIVAndSTIs/1311HIVintheUk2013report/
4 Rice BD, Elford J, Yin Z, Delpech VC. A new method to assign country of HIV infection among heterosexuals born abroad and diagnosed with HIV. AIDS 2012;26:1961-6.
5 Phillips AN, Cambiano V, Nakagawa F, Brown AE, Lampe F, Rodger A, et al. Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic. PLoS One 2013;8:e55312.
6 Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006;20:1447-50.
7 Reynolds SJ, Makumbi F, Nakigozi G, Kagaayi J, Gray RH, Wawer M, et al. HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy. AIDS 2011;25:473-7.
8 Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010;375:2092-8.CLINICAL REVIEW
9 Cohen MS, Smith MK, Muessig KE, Hallett TB, Powers KA, Kashuba AD. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet 2013;382:1515-24.
10 Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, et al. Late presentation of HIV infection: a consensus definition. HIV Med 2011;12:61-4.
11 National Institute for Health and Care Excellence. Increasing the uptake of HIV testing among black Africans in England. (Public Health Guidance PH33.) 2011. www.nice.org. uk/guidaance/PH33.
12 National Institute for Health and Care Excellence. Increasing the uptake of HIV testing among men who have sex with men. (Public Health Guidance PH34.) 2011. http://guidance.nice.org.uk/PH34.
13 Damery S, Nichols L, Holder R, Ryan R, Wilson S, Warmington S, et al. Assessing the predictive value of HIV indicator conditions in general practice: a case-control study using the THIN database. Br J Gen Pract 2013;63:e370-7.
14 Pao D, Fisher M, Hué S, Dean G, Murphy G, Cane PA, et al. Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections. AIDS 2005;19:85-90.
15 Fox J, White PJ, Macdonald N, Weber J, McClure M, Fidler S, et al. Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: a cohort of high-risk men who have sex with men. HIV Med 2009;10:432-8.
16 SPARTAC Trial Investigators, Fidler S, Porter K, Ewings F, Frater J, Ramjee G, et al. Short-course antiretroviral therapy in primary HIV infection. N Engl J Med 2013;368:207-17.
17 Sudarshi D, Pao D, Murphy G, Parry J, Dean G, Fisher M. Missed opportunities for diagnosing primary HIV infection. Sex Transm Infect 2008;84:14-6.
18 Sharrocks K, Jones CB, Naftalin C, Darling D, Fisher M, Fidler S, et al. Missed opportunities for identifying primary HIV within genitourinary medical/HIV services. Int J STD AIDS 2012;23:540-3.
19 Murphy G, Parry JV. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill 2008;13:pii:18966.
20 Hult JR, Maurer SA, Moskowitz JT. “I‘m sorry, you’re positive”: a qualitative study of individual experiences of testing positive for HIV. AIDS Care 2009;21:185-8.
21 Myers T, Worthington C, Aguinaldo JP, Haubrich DJ, Ryder K, Rawson B. Impact on HIV test providers of giving a positive test result. AIDS Care 2007;19:1013-9.
22 Anderson M, Elam G, Gerver S, Solarin I, Fenton K, Easterbrook P. “It took a piece of me”: initial responses to a positive HIV diagnosis by Caribbean people in the UK. AIDS Care 2010;22:1493-8.
23 Asboe D, Aitken C, Boffito M, Booth C, Cane P, Fakoya A, et al. British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med 2012;13:1-44.
24 Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75:3-17.
25 British HIV Association. HIV transmission, the law and the work of the clinical team. January 2013. www.bhiva.org/Reckless-HIV-Transmission-2013.aspx.
26 Moore AL, Sabin CA, Madge S, Mocroft A, Reid W, Johnson MA. Highly active antiretroviral therapy and cervical intraepithelial neoplasia. AIDS 2002;16:927-9.
27 Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS 2008;22:1203-11.
28 Berry JM, Palefsky JM, Jay N, Cheng S-C, Darragh TM, Chin-Hong PV. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. DisColon Rectum 2009;52:239-47.
29 Czoski-Murray C, Karnon J, Jones R, Smith K. Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer. Health Tech Assess 2010;14:iii-iv, ix-x, 1-101.
30 Egger M. Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet 2003;362:679-86.
31 Sabin CA, Devereux H, Phillips AN, Hill A,  Janossy G, Lee CA, et al. Course of viral load throughout HIV-1 infection. J Acquir Immune Defic Syndr 2000;23:172-7.
32 Ferreira A, Young T, Mathews C, Zunza M, Low N. Strategies for partner notification for sexually transmitted infections, including HIV. Cochrane Database Syst Rev 2013;10:CD002843.
33 British HIV Association, British Association for Sexual Health and HIV. Joint National Audit of the British HIV Association and the British Society for Sexual Health and HIV, 2013.
HIV partner notification processes and outcomes. www.bhiva.org/documents/ClinicalAudit/ FindingsandReports/PNsummaryResultsWeb.pptx.
34 Geretti AM, BHIVA Immunization Writing Committee, Brook G, Cameron C, Chadwick D, Heyderman RS, et al. British HIV Association guidelines for immunization of HIV-infected adults 2008. HIV Med 2008;9.795-848.
35 Williams I, Churchill D, Anderson J, Boffito M, Bower M, Cairns G, et al. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Med 2012;13(Suppl 2):1-85.
 

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022